drugset / Trial / NCT07817706

Development of a Noninvasive Metric to Measure Small Bowel Sensation - The Small Intestine Stress Test

NCT07817706 ↗

Recruiting 20 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this research is to identify the concentration of mannitol solution (a type of sugar alcohol) that will generate a range of symptoms in individuals without Disorders of Gut Brain Interaction (DGBI) to establish the normative range of responses to small bowel (SB) distension.

Timeline

Start
2026-09-01
Primary completion
2027-06-30
Completion
2027-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent 500 ml Oral

Indications

No indication recorded.